论文部分内容阅读
目的:探讨阿奇霉素治疗小儿支原体肺炎的方法和临床效果;方法:将2013年1月至2014年1月在我院接受治疗的小儿支原体肺炎患者46例,随机分为观察组23例(阿奇霉素治疗)和对照组23例(红霉素治疗),对比两组患儿的治疗效果;结果:对比两组患者治疗后效果发现,观察组的总有效率达到了95.65%(22/23),明显高于对照组73.91%(17/23),两组患者治疗效果对比差异有显著性(P<0.05);结论:与红霉素相比,阿奇霉素在治疗小儿支原体肺炎上有较好的耐受性和反应性等优势,可以应用到临床工作中。
Objective: To explore the method and clinical effect of azithromycin in the treatment of mycoplasma pneumonia in children.Methods: Forty-six children with mycoplasma pneumonia who were treated in our hospital from January 2013 to January 2014 were randomly divided into observation group (azithromycin treatment) And control group (erythromycin treatment). The therapeutic effect was compared between two groups. Results: Compared with the control group, the total effective rate of the observation group reached 95.65% (22/23), which was significantly higher than that of the control group In the control group 73.91% (17/23), the difference between the two groups was statistically significant (P <0.05). CONCLUSION: Compared with erythromycin, azithromycin is more tolerant to mycoplasma pneumonia in children And reactivity and other advantages, can be applied to clinical work.